Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Large Increase in Short Interest

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 20,471 shares, a growth of 822.9% from the January 29th total of 2,218 shares. Based on an average trading volume of 35,531 shares, the short-interest ratio is presently 0.6 days. Approximately 0.8% of the shares of the company are short sold. Approximately 0.8% of the shares of the company are short sold. Based on an average trading volume of 35,531 shares, the short-interest ratio is presently 0.6 days.

Invesco Nasdaq Biotechnology ETF Trading Down 0.5%

Shares of IBBQ stock traded down $0.16 during trading on Wednesday, reaching $29.98. 10,463 shares of the company’s stock traded hands, compared to its average volume of 47,956. Invesco Nasdaq Biotechnology ETF has a 1 year low of $17.84 and a 1 year high of $30.49. The company has a market capitalization of $75.25 million, a P/E ratio of 17.03 and a beta of 0.67. The firm’s 50-day moving average is $29.16 and its 200 day moving average is $26.90.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 26th. Investors of record on Monday, December 22nd were paid a dividend of $0.0906 per share. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date was Monday, December 22nd.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in IBBQ. Atria Investments Inc bought a new stake in Invesco Nasdaq Biotechnology ETF during the 2nd quarter worth approximately $211,000. Raymond James Financial Inc. purchased a new position in Invesco Nasdaq Biotechnology ETF during the second quarter worth about $149,000. IHT Wealth Management LLC bought a new position in Invesco Nasdaq Biotechnology ETF in the 2nd quarter worth about $211,000. Osaic Holdings Inc. boosted its position in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock valued at $101,000 after acquiring an additional 1,052 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Invesco Nasdaq Biotechnology ETF by 7.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 215,722 shares of the company’s stock worth $5,245,000 after purchasing an additional 14,717 shares in the last quarter.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.